Profilo
Maud Brandely worked as the Director of Oncology Clinical Development at Pierre Fabre SA and as the Director of Taxotere Clinical Development at Rhone-Poulenc SA. From 2016 to 2024, Dr. Brandely served as the Chief Medical Officer & VP of Medical Affairs at Transgene SA. Dr. Brandely obtained a graduate and doctorate degree from Université Pierre et Marie Curie.
Precedenti posizioni note di Maud Brandely
| Società | Posizione | Fine |
|---|---|---|
| TRANSGENE | Direttore Tecnico/Scientifico/R&S | 10/09/2024 |
Pierre Fabre SA
Pierre Fabre SA BiotechnologyHealth Technology Engages in research and preclinical development of biologics & pharmaceuticals | Corporate Officer/Principal | 01/02/2016 |
Rhone-Poulenc SA
Rhone-Poulenc SA Chemicals: SpecialtyProcess Industries Manufactures and supplies chemicals | Corporate Officer/Principal | - |
Formazione di Maud Brandely
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Transgene SA
Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Pierre Fabre SA
Pierre Fabre SA BiotechnologyHealth Technology Engages in research and preclinical development of biologics & pharmaceuticals | Health Technology |
Rhone-Poulenc SA
Rhone-Poulenc SA Chemicals: SpecialtyProcess Industries Manufactures and supplies chemicals | Process Industries |
Université Pierre et Marie Curie
Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















